A new biotechnology company demonstrated in lab mice its therapy for glioblastoma, an aggressive brain cancer, that overcomes limitations of current treatments. . . . → Read More: Biotech Start-Up Demonstrates Cancer Therapy, Raises $6.4M
|
|||||
       |
 Comments are closed  Finance, New products  biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, physical sciences, preclinical, university, venture capital 
Two companies working in women’s reproductive health are developing a new non-hormonal contraceptive that works in cervical mucous membranes. . . . → Read More: Women’s Health Companies Partner on New Contraceptive Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, challenge, entrepreneurs, Europe, licensing, life sciences, medical device, NIH, pharmaceuticals, preclinical 
Two biotechnology companies are advancing basic research findings connecting gut microbes with the brain to develop new therapies for neurological disorders. . . . → Read More: Biotechs Explore Gut-Brain Axis for Mental Health One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, entrepreneurs, investment, licensing, life sciences, pharmaceuticals, university 
An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells. . . . → Read More: CEPI Funds New Broad Coronavirus Vaccine One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, Covid-19, Europe, genomics, grant, licensing, life sciences, nanotechnology, preclinical, university 
A biotechnology company is licensing a gene-editing enzyme to Novartis to create treatments for inherited blood disorders such as sickle cell disease. . . . → Read More: Biotech in $1.5B Gene-Editing Tech License Deal Comments are closed Intellectual property, New products biomedical, biotechnology, Europe, genomics, licensing, life sciences, pharmaceuticals 
A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes. . . . → Read More: Companies Partner on Implanted Diabetes Beta Cell Device Comments are closed Finance, Intellectual property, Joint ventures/collaborations biomedical, biotechnology, Canada, equity, Europe, investment, licensing, life sciences, medical device, stem cells 
Early results from a clinical trial show an experimental gene transfer therapy largely reduces painful events from sickle cell disease for one to two years. . . . → Read More: Trial Shows Gene Therapy Results with Sickle Cell Disease Comments are closed New products biomedical, biotechnology, clinical trials, genomics, licensing, life sciences, pharmaceuticals, stem cells 
A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds. . . . → Read More: Semiconductor Tech Drug Discovery Company Underway One comment - (Comments are closed) Finance, New products biomedical, chemistry, computer science, engineering, entrepreneurs, equity, investment, licensing, life sciences, nanotechnology, pharmaceuticals, physical sciences, physics, preclinical, semiconductors, university, venture capital 
Lab studies show an experimental synthetic antibody protects animals and neutralizes all SARS-CoV-2 variants of concern, including omicron BA.2. . . . → Read More: Preclinical Tests Show Antibody Stops Covid-19 Variants One comment - (Comments are closed) New products biomedical, biotechnology, Covid-19, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals, venture capital 
A study with a small chip device simulating human lung functions shows normal breathing generates immune responses that protect against respiratory diseases. . . . → Read More: Lung Chip Reveals Respiratory Immune Responses Comments are closed New products biomedical, Covid-19, engineering, licensing, life sciences, medical device, pharmaceuticals, preclinical, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts